Sanofi, GSK Agree With UK Government to Supply Up to 60 Million Doses of Covid-19 Vaccine
29 Julio 2020 - 12:54AM
Noticias Dow Jones
By Ian Walker
Sanofi S.A. and GlaxoSmithKline PLC said Wednesday that they
have reached an agreement with the U.K. government to supply up to
60 million doses of a Covid-19 vaccine, subject to final
contract.
The French and U.K. pharmaceutical companies said the vaccine
candidate is based on Sanofi's technology that produces an
influenza vaccine as well as GSK's pandemic adjuvant
technology.
Sanofi is leading clinical development and registration of the
Covid-19 vaccine and plans a Phase 1, 2 study in September,
followed by a Phase 3 study by the end of the year. If data proves
positive, regulatory approval could be received in the first half
of next year, it said.
Write to Ian Walker at ian.walker@wsj.com
(END) Dow Jones Newswires
July 29, 2020 01:39 ET (05:39 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
